As of 2025-05-03, the Intrinsic Value of China Resources Medical Holdings Company Ltd (1515.HK) is 5.89 HKD. This 1515.HK valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 3.67 HKD, the upside of China Resources Medical Holdings Company Ltd is 60.40%.
The range of the Intrinsic Value is 4.84 - 7.51 HKD
Based on its market price of 3.67 HKD and our intrinsic valuation, China Resources Medical Holdings Company Ltd (1515.HK) is undervalued by 60.40%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 4.84 - 7.51 | 5.89 | 60.4% |
| DCF (Growth 10y) | 5.81 - 8.94 | 7.04 | 92.0% |
| DCF (EBITDA 5y) | 7.93 - 10.68 | 9.34 | 154.4% |
| DCF (EBITDA 10y) | 8.28 - 11.85 | 9.99 | 172.2% |
| Fair Value | 8.77 - 8.77 | 8.77 | 138.89% |
| P/E | 5.48 - 12.43 | 7.80 | 112.5% |
| EV/EBITDA | 3.66 - 7.34 | 5.48 | 49.3% |
| EPV | (2.67) - (3.44) | (3.05) | -183.2% |
| DDM - Stable | 2.18 - 4.27 | 3.23 | -12.1% |
| DDM - Multi | 2.71 - 4.41 | 3.37 | -8.0% |
| Market Cap (mil) | 4,758.82 |
| Beta | 1.15 |
| Outstanding shares (mil) | 1,296.68 |
| Enterprise Value (mil) | 5,417.80 |
| Market risk premium | 5.98% |
| Cost of Equity | 12.87% |
| Cost of Debt | 4.56% |
| WACC | 9.55% |